Kumar A - Search Results

1

Is viral E6 oncoprotein a viable target? A critical analysis in the context of cervical cancer.

Kumar A, Rathi E, Hariharapura RC, Kini SG. Kumar A, et al. Med Res Rev. 2020 Sep;40(5):2019-2048. doi: 10.1002/med.21697. Epub 2020 Jun 2. Med Res Rev. 2020. PMID: 32483862 Review.

2

Potentials of Diphenyl Ether Scaffold as a Therapeutic Agent: A Review.

Kini SG, Rathi E, Kumar A, Bhat V. Kini SG, et al. Among authors: kumar a. Mini Rev Med Chem. 2019;19(17):1392-1406. doi: 10.2174/1389557519666190312150132. Mini Rev Med Chem. 2019. PMID: 30864517 Review.

3

Targeting HIV-TB coinfection by developing novel piperidin-4-substituted imines: Design, synthesis, in vitro and in silico studies.

Kumar A, Revathi R, Sriram D, Curreli F, Debnath AK, Pai KS, Kini SG. Kumar A, et al. Arch Pharm (Weinheim). 2019 Jun;352(6):e1800358. doi: 10.1002/ardp.201800358. Epub 2019 May 8. Arch Pharm (Weinheim). 2019. PMID: 31066103

4

Identification of potential tumour-associated carbonic anhydrase isozyme IX inhibitors: atom-based 3D-QSAR modelling, pharmacophore-based virtual screening and molecular docking studies.

Kumar A, Rathi E, Kini SG. Kumar A, et al. J Biomol Struct Dyn. 2020 Apr;38(7):2156-2170. doi: 10.1080/07391102.2019.1626285. Epub 2019 Jun 8. J Biomol Struct Dyn. 2020. PMID: 31179854

5

Molecular dynamics guided insight, binding free energy calculations and pharmacophore-based virtual screening for the identification of potential VEGFR2 inhibitors.

Rathi E, Kumar A, Kini SG. Rathi E, et al. Among authors: kumar a. J Recept Signal Transduct Res. 2019 Oct-Dec;39(5-6):415-433. doi: 10.1080/10799893.2019.1690509. Epub 2019 Nov 22. J Recept Signal Transduct Res. 2019. PMID: 31755336

6

Pharmacophore-guided fragment-based design of novel mammalian target of rapamycin inhibitors: extra precision docking, fingerprint-based 2D and atom-based 3D-QSAR modelling.

Kumar A, Rai S, Rathi E, Agarwal P, Kini SG. Kumar A, et al. J Biomol Struct Dyn. 2021 Mar;39(4):1155-1173. doi: 10.1080/07391102.2020.1726816. Epub 2020 Feb 19. J Biomol Struct Dyn. 2021. PMID: 32037974

7

Computational approaches in efflux pump inhibitors: current status and prospects.

Rathi E, Kumar A, Kini SG. Rathi E, et al. Among authors: kumar a. Drug Discov Today. 2020 Oct;25(10):1883-1890. doi: 10.1016/j.drudis.2020.07.011. Epub 2020 Jul 23. Drug Discov Today. 2020. PMID: 32712312 Review.

8

Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study.

Sankhe R, Rathi E, Manandhar S, Kumar A, Pai SRK, Kini SG, Kishore A. Sankhe R, et al. Among authors: kumar a. J Mol Struct. 2021 Jan 15;1224:129073. doi: 10.1016/j.molstruc.2020.129073. Epub 2020 Aug 12. J Mol Struct. 2021. PMID: 32834116 Free PMC article.

9

Exploration of small-molecule entry disruptors for chikungunya virus by targeting matrix remodelling associated protein.

Kumar A, Rathi E, Kini SG. Kumar A, et al. Res Pharm Sci. 2020 Jul 3;15(3):300-311. doi: 10.4103/1735-5362.288437. eCollection 2020 Jun. Res Pharm Sci. 2020. PMID: 33088330 Free PMC article.

10

Computer-aided identification of human carbonic anhydrase isoenzyme VII inhibitors as potential antiepileptic agents.

Kumar A, Agarwal P, Rathi E, Kini SG. Kumar A, et al. J Biomol Struct Dyn. 2022 Jul;40(11):4850-4865. doi: 10.1080/07391102.2020.1862706. Epub 2020 Dec 21. J Biomol Struct Dyn. 2022. PMID: 33345714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,149 results

Search Page

Filters